Advertisement
Research Article| Volume 7, ISSUE 2, P113-127, March 1998

Assessment scales for the evaluation of stroke patients

  • Patrick D. Lyden
    Correspondence
    Address reprint requests to Patrick D. Lyden, MD, University of California at San Diego, 200 W Arbor Dr, San Diego, CA 92103-8466.
    Affiliations
    The University of California at San Diego Stroke Center, Department of Neurology, Veterans Affairs Medical Center, San Diego, CA, USA

    Janssen Research Foundation, Titusville, NJ, USA
    Search for articles by this author
  • Ludwig Hantson
    Affiliations
    The University of California at San Diego Stroke Center, Department of Neurology, Veterans Affairs Medical Center, San Diego, CA, USA

    Janssen Research Foundation, Titusville, NJ, USA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.
      The approval of tissue plasminogen activator to treat acute ischemic stroke and the continuing need to evaluate new neuroprotective drugs and thrombolytic agents in clinical trials have focused interest on the quantitative evaluation of stroke patients. Emphasizing outcomes management in clinical practice has also heightened the importance of quantitative evaluation using assessment scales. Investigators who evaluate, revise, and use assessment scales for the measurement of stroke impairment, disabilites, and handicaps face many challenges. These problems include the heterogeneity of stroke and the need to determine appropriate outcome measures, to use neurological deficit scales that can accurately predict disability, to ensure adequate follow-up, and to use scales that can be used outside of clinical trials by all health care professionals. Such scales should be easily and quickly administered, responsive, valid, and reliable. The most important categories of stroke scales are neurological deficit scales (e.g., Canadian Neurological Scale, European Stroke Scale, and National Institutes of Health [NIH] Stroke Scale), functional outcome scales (e.g., Barthel Index), and global outcome scales (e.g., Modified Rankin Scale). Although stroke-specific, health-related quality-of-life (HRQL) scales have yet to be developed and validated, general HRQL scales such as the Nottingham Health Profile, the Medical Outcomes Study Short Form-36, the Sickness Impact Profile, and the Health Utilities Index may be used to assess stroke patients. Lacking the ideal single stroke outcome scale, we continue to recomend a combination of scales: the NIH Stroke Scale (or similar deficit scale), the Barthel Index, and the Rankin Scale.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Asplund K
        Clinimetrics in stroke research.
        Stroke. 1987; 18: 528-530
        • Hantson L
        • De Weerdt W
        • De Keyser J
        • et al.
        The European Stroke Scale.
        Stroke. 1994; 25: 2215-2219
        • Fisher M
        • Bogousslavsky J
        Evolving toward effective therapy for acute ischemic stroke.
        JAMA. 1993; 270: 360-364
        • Bogousslavsky J
        Acute stroke trials: From morass to nirvana?.
        Cerebrovas Dis. 1995; 5: 3-6
      1. a
        • Their SO
        Forces motivating the use of health status assessment measures in clinical settings and related clinical research.
        Med Care. 1992; 30 (suppl): MS15-MS22
        • Candelise L
        Stroke scores and scales.
        Cerebrovasc Dis. 1992; 2: 239-247
        • Adams Jr, HP
        Trials of trials in acute ischemic stroke: The Humana Lecture.
        Stroke. 1993; 24: 1410-1415
        • Lyden PD
        • Lau GT
        A critical appraisal of stroke evaluation and rating scales.
        Stroke. 1991; 11: 1345-1352
        • Feinstein AR
        • Josephy BR
        • Wells CK
        Scientific and clinical problems in indexes of functional disability.
        Ann Intern Med. 1986; 105: 413-420
        • Steiner TJ
        • Clifford Rose F
        Towards a model stroke trial: The single-centre naftidrofuryl study.
        Neuroepidemiology. 1986; 5: 121-147
        • World Health Organization
        International classification of impairments, disabilities, and handicaps.
        in: World Health Organization, Geneva1993
        • Orgogozo JM
        The concepts of impairment, disability, and handicap.
        Cerebrovasc Dis. 1994; 4: 2-6
        • Gresham GE
        Rehabilitation of the stroke survivor.
        in: Barnett HJM Mohr JP Stein BM Stroke: Pathophysiology, diagnosis, and management. 2nd Ed. Churchill Livingstone, New York1992: 1189-1201
        • Adams Jr, HP
        • Bendixen BH
        • Kappelle LJ
        • et al.
        Classification of subtype of acute ischemic stroke: Definitions for use in a multicenter clinical trial.
        Stroke. 1993; 24: 35-41
        • Gresham GE
        • Phillips TF
        • Wolf PA
        • et al.
        Epidemiologic profile of long-term stroke disability: The Framingham study.
        Arch Phys Med Rehabil. 1979; 60: 487-491
        • Spence JD
        • Donner A
        Problems in design of stroke treatment trials.
        Stroke. 1982; 13: 94-99
        • The National Institute of Neurological Disorders and Stroke t-PA Stroke Study Group
        Tissue plasminogen activator for acute ischemic stroke.
        N Engl J Med. 1995; 333: 1581-1587
        • Jennett B
        • Bond M
        Assessment of outcome after severe brain damage: A practical scale.
        Lancet. 1975; 7905: 480-484
        • Teasdale G
        • Knill-Jones R
        • van der Sande J
        Observer variability in assessing impaired consciousness and coma.
        J Neurol Neurosurg Psychiatry. 1978; 41: 603-610
        • De Haan R
        • Horn J
        • Limburg M
        • et al.
        A comparison of five stroke scales with measures of disability, handicap, and quality of life.
        Stroke. 1993; 24: 1178-1181
        • Hantson L
        • De Keyser J
        Neurological scales in the assessment of cerebral infarction.
        Cerebrovasc Dis. 1994; 4: 7-14
        • Orgogozo JM
        • Dartigues JF
        Clinical trials in acute brain infarction: The question of assessment criteria.
        in: Battistini N Acute brain ischemia: Medical and surgical therapy. Raven, New York1985: 201-208
        • Orgogozo JM
        • Dartigues JF
        Methodology of clinical trials in acute cerebral ischemia: Survival, functional, and neurological outcome measures.
        Cerebrovasc Dis. 1991; 1: 100-111
        • Lenzi GL
        • Di Piero V
        • Zanette E
        • et al.
        How to assess acute cerebral ischemia.
        Cerebrovasc Brain Metab Rev. 1991; 3: 179-212
        • Kinsella G
        • Ford B
        Acute recovery patterns in stroke patients.
        Med J Aust. 1980; 2: 663-666
        • Skilbeck CE
        • Wade DT
        • Langton Hewer R
        • et al.
        Recovery after stroke.
        J Neurol Neurosurg Psychiatry. 1983; 46: 5-8
        • Andrews K
        • Brocklehurst JC
        • Richards B
        • et al.
        The rate of recovery from stroke and its measurement.
        Int Rehabil Med. 1981; 3: 155-161
        • Werner RA
        • Kessler S
        Effectiveness of an intensive outpatient rehabilitation program for postacute stroke patients.
        Am J Phys Med Rehabil. 1996; 75: 114-120
        • van Swieten JC
        • Koudstaal PJ
        • Visser MC
        • et al.
        Interobserver agreement for the assessment of handicap in stroke patients.
        Stroke. 1988; 19: 604-607
        • Mahoney FI
        • Barthel DW
        Functional evaluation: The Barthel Index.
        MD State Med J. 1965; 14: 61-65
        • Olesen J
        • Simonsen K
        • Norgaard B
        • et al.
        Reproducibility and utility of a simple neurological scoring system for stroke patients (Copenhagen Stroke Scale).
        J Neurol Rehabil. 1988; 2: 59-63
        • Wright JG
        • Feinstein AR
        A comparative contrast of clinimetric and psychometric methods for constructing indexes and rating scales.
        J Clin Epidemiol. 1992; 45: 1201-1218
        • van Bennekom CAM
        • Jelles F
        • Lankhorst GJ
        • et al.
        Responsiveness of the rehabilitation activities profile and the Barthel Index.
        J Clin Epidemiol. 1996; 49: 39-44
        • Lyden P
        • Brott T
        • Tilley B
        • et al.
        Improved reliability of the NIH Stroke Scale using video training.
        Stroke. 1994; 25 (In: Haley EC, Grotta J, Marler J, et al.): 2220-2226
        • Albanese MA
        • Clarke WR
        • Adams Jr, HP
        • et al.
        Ensuring reliability of outcome measures in multicenter clinical trials of treatments for acute ischemic stroke: The program developed for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST).
        Stroke. 1994; 25: 1746-1751
        • Côté R
        • Hachinski VC
        • Shurvell BL
        • et al.
        The Canadian Neurological Scale: A preliminary study in acute stroke.
        Stroke. 1986; 17: 731-737
        • Côté R
        • Battista RN
        • Wolfson C
        • et al.
        The Canadian Neurological Scale: Validation and reliability assessment.
        Neurology. 1989; 39: 638-643
        • Fugl-Meyer AR
        • Jääskö L
        • Leyman I
        • et al.
        The post-stroke hemiplegic patient. I: A method for evaluation of physical performance.
        Scand J Rehabil Med. 1975; 7: 13-31
        • Fugl-Meyer AR
        • Jääskö L
        Post-stroke hemiplegia and ADL performance.
        Scand J Rehabil Med. 1980; 7 (suppl): 140-152
        • Lindmark B
        • Hamrin E
        Evaluation of functional capacity after stroke as a basis for active intervention: Validation of a modified chart for motor capacity assessment.
        Scand J Rehabil Med. 1988; 20: 111-115
        • Nunnally JC
        2nd Ed. Psychometric Theory. McGraw-Hill, New York1978
        • Adams RJ
        • Meador KJ
        • Sethi KD
        • et al.
        Graded neurologic scale for use in acute hemispheric stroke treatment protocols.
        Stroke. 1987; 18: 665-669
        • Brown EB
        • Tietjen GE
        • Deveshwar RK
        • et al.
        Clinical stroke scales: An intra- and inter-scale evaluation.
        Neurology. 1990; 40 ([poster]): 352
        • Mathew NT
        • Rivera VM
        • Meyer JS
        • et al.
        Double-blind evaluation of glycerol therapy in acute cerebral infarction.
        Lancet. 1972; ii: 1327-1329
        • Frithz G
        • Werner I
        Studies on cerebrovascular strokes. II: Clinical findings and short-term prognosis in a stroke material.
        Acta Med Scand. 1976; 199: 133-140
        • Gelmers HJ
        • Gorter K
        • de Weerdt CJ
        • et al.
        Assessment of interobserver variability in a Dutch, multicenter study on acute ischemic stroke.
        Stroke. 1988; 19: 709-711
        • Koller M
        • Haenny P
        • Hess K
        • et al.
        Adjusted hypervolemic hemodilution in acute ischemic stroke.
        Stroke. 1990; 21: 1429-1434
        • Brott T
        • Adams HP
        • Olinger CP
        • et al.
        Measurements of acute cerebral infarction: A clinical examination scale.
        Stroke. 1989; 20: 864-870
        • Goldstein LB
        • Bertels C
        • Davis JN
        Interrater reliability of the NIH stroke scale.
        Arch Neurol. 1989; 46: 660-662
        • Scandinavian Stroke Study Group
        Multicenter trial of hemodilution in ischemic stroke: Background and study protocol.
        Stroke. 1985; 16: 885-890
        • Scandinavian Stroke Study Group
        Multicenter trial of hemodilution in ischemic stroke. I: Results in the total patient population.
        Stroke. 1987; 18: 691-699
        • Scandinavian Stroke Study Group
        Multicenter trial of hemodilution in acute ischemic stroke: Results of subgroup analyses.
        Stroke. 1988; 19: 464-471
        • Lindenström E
        • Boysen G
        • Christiansen LW
        • et al.
        Reliability of Scandinavian Neurological Stroke Scale.
        Cerebrovasc Dis. 1991; 1: 103-107
        • Norris JW
        Steroid therapy in acute cerebral infarction.
        Arch Neurol. 1976; 33: 69-71
        • Norris JW
        • Hachinski VC
        Comment on “Study design of stroke treatments”.
        Stroke. 1982; 13: 527-528
        • Fiorelli M
        • Alpérovitch A
        • Argentino C
        • et al.
        Prediction of long-term outcome in the early ours following acute ischemic stroke.
        Arch Neurol. 1995; 52: 250-255
        • Diener HC
        • Hacke W
        • Hennerici M
        • et al.
        Lubeluzole in acute ischemic stroke: A double-blind, placebo-controlled phase II trial.
        Stroke. 1996; 27: 76-81
        • Haley Jr, EC
        • Levy DE
        • Brott TG
        • et al.
        Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91–180 minutes from onset.
        Stroke. 1992; 23: 641-645
        • Gresham GE
        • Phillips TF
        • Labi MLC
        ADL status in stroke: Relative merits of three standard indexes.
        Arch Phys Med Rehabil. 1980; 61: 355-358
        • Donaldson SW
        • Wagner CC
        • Gresham GE
        A unified ADL evaluation form.
        Arch Phys Med Rehabil. 1973; 54: 175-179
        • Lyden PD
        • Broderick J
        • Mascha E
        • et al.
        Reliability of the Barthel Index outcome measure selected for the NINDS t-PA Stroke Trial.
        in: Yamaguchi T Mori E Minematsu K Thrombolytic therapy in acute stroke III. Springer-Verlag, Tokyo, Japan1996
        • Wade DT
        • Skilbeck CE
        • Langton Hewer R
        Predicting Barthel ADL score at 6 months after an acute stroke.
        Arch Phys Med Rehabil. 1983; 64: 24-28
        • Granger CV
        • Dewis LS
        • Peters NC
        • et al.
        Stroke rehabilitation: Analysis of repeated Barthel index measures.
        Arch Phys Med Rehabil. 1979; 60: 14-17
        • Wade DT
        • Collin C
        The Barthel ADL Index: A standard measure of physical disability?.
        Int Disabil Stud. 1988; 10: 64-67
        • Granger CV
        • Hamilton BB
        • Linacre JM
        • et al.
        Performance profiles of the Functional Independence Measure.
        Am J Phys Med Rehabil. 1993; 72: 84-89
        • Grimby G
        Quantification of disability after stroke.
        Cerebrovasc Dis. 1994; 4: 15-18
        • Granger CV
        • Hamilton BB
        The uniform data system for medical rehabilitation report of first admissions for 1992.
        Am J Phys Med Rehabil. 1994; 73: 51-55
        • Hamrin E
        • Wohlin A
        Evaluation of the functional capacity of stroke patients through an activity index.
        Scand J Rehabil Med. 1982; 14: 93-100
        • Katz S
        • Ford AB
        • Moskowitz RW
        • et al.
        Studies of illness in the aged. The Index of ADL: A standardized measure of biological and psychosocial function.
        JAMA. 1963; 185: 914-919
        • Schoening HA
        • Anderegg L
        • Bergstrom D
        • et al.
        Numerical scoring of self-care status of patients.
        Arch Phys Med Rehabil. 1965; 46: 689-697
        • Granger CV
        • Albrecht GL
        • Hamilton BB
        Outcome of comprehensive medical rehabilitation: Measurement by PULSES profile and the Barthel Index.
        Arch Phys Med Rehabil. 1979; 60: 145-154
        • van Bennekom CA
        • Jelles F
        • Lankhorst GJ
        Rehabilitation Activities Profile, the ICIDH as a framework for a problem-oriented assessment method in rehabilitation medicine.
        Disabil Rehabil. 1995; 17: 169-175
        • Granger CV
        • Hamilton BB
        • Gresham GE
        • et al.
        The Stroke Rehabilitation Outcome Study: Part II. Relative merits of the total Barthel Index score and a four-item subscore in predicting patient outcomes.
        Arch Phys Med Rehabil. 1989; 70: 100-103
        • Rankin J
        Cerebral vascular accidents in patients over the age of 60: II. Prognosis.
        Scot Med J. 1957; 2: 200-215
        • Testa MA
        • Simonson DC
        Assessment of quality-of-life outcomes.
        N Engl J Med. 1996; 334: 835-840
      2. Quality of life and clinical trials.
        Lancet. 1995; 346 (Anonymous): 1-2
        • Guyatt GH
        • Naylor CD
        • Juniper E
        • et al.
        User's guides to the medical literature: XII. How to use articles about health-related quality of life.
        JAMA. 1997; 277: 1232-1237
        • Bergner M
        Quality of life, health status, and clinical research.
        Med Care. 1989; 27 (suppl): S148-S156
        • Testa MA
        • Lenderking WR
        Interpreting pharmacoeconomic and quality-of-life clinical trial data for use in therapeutics.
        Pharmaco Economics. 1992; 2: 107-117
        • Testa MA
        • Nackley JF
        Methods for quality-of-life studies.
        Annu Rev Public Health. 1994; 15: 535-559
        • Tate DG
        • Dijkers M
        • Johnson-Greene L
        Outcome measures in quality of life.
        Top Stroke Rehabil. 1996; 2: 1-17
        • Gill TM
        • Feinstein AR
        A critical appraisal of the quality of quality-of-life measurements.
        JAMA. 1994; 272: 619-626
        • Berzon RA
        • Simeon GP
        • Simpson Jr, RL
        • et al.
        Quality of life bibliography and lindexes: 1993 update.
        Qual Life Res. 1995; 4: 53-74
        • Guyatt GH
        • Cook DJ
        Health status, quality of life, and the individual.
        JAMA. 1994; 272 ([editorial]): 630-631
        • Brass LM
        Trial design issues: End points and sample size.
        Cerebrovasc Dis. 1995; 5: 3-11
        • Widén Holmqvist L
        • de Pedro Cuesta J
        • Möller G
        • et al.
        A pilot study of rehabilitation at home after stroke: A health-economic appraisal.
        Scand J Rehabil Med. 1996; 28: 9-18
        • Hunt SM
        • McEwen J
        • McKenna SP
        The Nottingham Health Profile user's manual.
        Galen Research & Consultancy, Manchester1981
        • Anderson RT
        • Aaronson NK
        • Wilkin D
        Critical review of the international assessments of health-related quality of life.
        Qual Life Res. 1993; 2: 369-395
        • Beaton DE
        • Bombardier C
        • Hogg-Johnson SA
        Measuring health in injured workers: A cross-sectional comparison of five generic health status instruments in workers with musculoskeletal injuries.
        Am J Ind Med. 1996; 29: 618-631
        • Ware Jr, JE
        • Sherbourne CD
        The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.
        Med Care. 1992; 30: 473-483
        • Bergner M
        • Bobbitt RA
        • Kressel S
        • et al.
        The Sickness Impact Profile: Conceptual formulation and methodology for the development of a health status measure.
        Int J Health Serv. 1976; 6: 393-415
        • Bergner M
        • Bobbitt RA
        • Carter WB
        • et al.
        The Sickness Impact Profile: Development and final revision of a health status measure.
        Med Care. 1981; 19: 787-805
        • Post MW
        • de Bruin A
        • de Witte L
        • et al.
        The SIP68: A measure of health-related functional status in rehabilitation medicine.
        Arch Phys Med Rehabil. 1996; 77: 440-445
      3. (Anonymous)
        Multi-attribute health status classification questionnaire.
        Technology Assessment Group, San Francisco1994
        • Feeny D
        • Furlong W
        • Barr RD
        • et al.
        A comprehensive multiattribute system for calssifying the health status of survivors of childhood cancer.
        J Clin Oncol. 1992; 10: 923-928
        • Prieto L
        • Alonso J
        • Viladrich MC
        • et al.
        Scaling the Spanish version of the Nottingham Health Profile: Evidence of limited value of item weights.
        J Clin Epidemiol. 1996; 49: 31-38
        • Essink-Bot ML
        • Krabbe PFM
        • Van Agt HME
        • et al.
        NHP or SIP: A comparative study in renal insufficiency associated anemia.
        Qual Life Res. 1996; 5: 91-100
        • Stewart AL
        • Greenfield S
        • Hays RD
        • et al.
        Functional status and well-being of patients with chronic conditions: Results from the Medical Outcomes Study.
        JAMA. 1989; 262: 907-913
        • Katz JN
        • Larson MG
        • Phillips CB
        • et al.
        Comparative measurement sensitivity of short and longer health status instruments.
        Med Care. 1992; 30: 917-925
        • VanderZee KI
        • Sanderman R
        • Heyink J
        A comparison of two multidimensional measures of health status: The Nottingham Health Profile and the RNAD 36-Item Health Survey 1.0.
        Qual Life Res. 1996; 5: 165-174
        • Rothman ML
        • Hedrick S
        • Inui T
        The Sickness Impact Profile as a measure of the health status of noncognitively impaired nursing home residents.
        Med Care. 1989; 27: 157-167
        • Finlay AY
        • Khan GK
        • Luscombe DK
        • et al.
        Validation of the Sickness Impact Profile and Psoriasis Disability Index in Psoriasis.
        Br J Dermatol. 1990; 123: 751-756
        • Jones PW
        • Baveystock C
        • Littlejohns P
        Relationships between general health measured with the Sickness Impact Profile and respiratory symptoms, physiological measures and mood in patients with chronic airflow limitation.
        Am Rev Respir Dis. 1989; 140: 1538-1543
        • Deyo RA
        • Inui TS
        • Leininger JD
        • et al.
        Measuring functional outcomes in chronic disease: A comparison of traditional scales and a self-administered health status questionnaire in patients with rheumatoid arthritis.
        Med Care. 1983; 21: 180-192
        • Pollard WE
        • Bobbitt RA
        • Bergner M
        • et al.
        The Sickness Impact Profile: Reliability of a health status measure.
        Med Care. 1983; 14: 146-155
        • Deyo RA
        • Inui TS
        Toward clinical applications of health status measures: Sensitivity of scales to clinically important changes.
        Health Serv Res. 1984; 19: 277-289
        • MacKenzie CR
        • Charlson ME
        • DiGioia D
        • et al.
        Can the Sickness Impact Profile measure change? An example of scale assessment.
        J Chronic Dis. 1986; 39: 429-438
        • Katz JN
        • Phillips CB
        • Fossel AH
        • et al.
        Stability and responsiveness of utility measures.
        Med Care. 1994; 32: 183-188
        • Fanshel S
        • Bush JW
        A health status index and its application to health services outcomes.
        Oper Res. 1970; 186: 1021-1066